CodeLab Capital AS (OSL: CODE)
Norway
· Delayed Price · Currency is NOK 0.250
-0.049 (-16.39%)
Aug 30, 2024, 4:25 PM CET
CodeLab Capital AS Revenue
CodeLab Capital AS had revenue of 60.67K NOK in the quarter ending March 31, 2024, a decrease of -99.88%. This brings the company's revenue in the last twelve months to 47.39M, down -75.19% year-over-year. In the year 2023, CodeLab Capital AS had annual revenue of 93.85M, down -51.87%.
Revenue (ttm)
47.39M
Revenue Growth
-75.19%
P/S Ratio
n/a
Revenue / Employee
1.63M
Employees
29
Market Cap
85.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 93.85M | -101.15M | -51.87% |
| Dec 31, 2022 | 195.01M | -13.63M | -6.53% |
| Dec 31, 2021 | 208.63M | 68.85M | 49.26% |
| Dec 31, 2020 | 139.78M | 24.97M | 21.75% |
| Dec 31, 2019 | 114.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 533.17M |
| Nordhealth AS | 471.77M |
| Nykode Therapeutics AS | 69.44M |
| Photocure ASA | 513.58M |
| Carasent ASA | 254.01M |
| ArcticZymes Technologies ASA | 117.80M |
| Hofseth BioCare ASA | 230.08M |
| Gentian Diagnostics ASA | 151.51M |